首页> 美国卫生研究院文献>Brain and Behavior >Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging
【2h】

Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging

机译:药敏加权成像鉴别原发性中枢神经系统淋巴瘤与高级神经胶质瘤和脑转移瘤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and PurposeConventional MRI is often difficult to distinguish between primary central nervous system lymphomas (PCNSLs), high-grade gliomas and brain metastases due to the similarity of their appearance. The aim of this study was to investigate whether the susceptibility-weighted imaging (SWI) has higher sensitivity than conventional MRI in detecting hemorrhage between PCNSLs, high-grade gliomas and brain metastases, and can be used to differentiate the diagnosis between these tumors.
机译:背景与目的常规MRI由于外观相似,通常难以区分原发性中枢神经系统淋巴瘤(PCNSL),高级神经胶质瘤和脑转移瘤。这项研究的目的是调查在检测PCNSL,高级别神经胶质瘤和脑转移瘤之间的出血方面,敏感性加权成像(SWI)是否比常规MRI具有更高的敏感性,并且可以用于区分这些肿瘤的诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号